Related Experiment Videos
RNA interference prevents lipopolysaccharide-induced preprotachykinin gene expression
Yih-Loong Lai1, Shu Chuan Yu, Mei-Jung Chen
1Department of Physiology, National Taiwan University College of Medicine, Taipei 100, Taiwan. tiger@ha.mc.ntu.edu.tw
Toxicology and Applied Pharmacology
|November 14, 2003
Summary
Double-stranded preprotachykinin (ds PPT) RNA, a form of RNA interference (RNAi), effectively prevents lipopolysaccharide-induced airway hyperreactivity by blocking tachykinin synthesis. This targeted RNAi approach offers a novel strategy for modulating airway responses.
Area of Science:
- Neuroscience
- Pulmonology
- Molecular Biology
Background:
- Lipopolysaccharide (LPS) exposure triggers noncholinergic airway hyperreactivity.
- This hyperreactivity is linked to increased tachykinin synthesis, a key pathway in airway inflammation and bronchoconstriction.
Purpose of the Study:
- To investigate whether double-stranded preprotachykinin (ds PPT) RNA, utilizing RNA interference (RNAi), can prevent LPS-induced airway alterations.
- To assess the efficacy of local RNAi application in modulating the noncholinergic system affecting the airways.
Main Methods:
- Primary nodose ganglial cells and young Brown-Norway rats were used for in vitro and in vivo studies, respectively.
- Groups included control, LPS exposure, and LPS exposure with ds PPT RNA microinjection into nodose ganglia.
- Analysis involved measuring PPT mRNA and substance P (SP) levels, alongside in vivo airway reactivity to capsaicin.
Main Results:
- LPS significantly increased PPT mRNA and SP levels both in vitro and in vivo.
- Airway reactivity to capsaicin was significantly elevated in LPS-exposed rats.
- Administration of ds PPT RNA, but not scrambled RNA, successfully prevented all LPS-induced increases in PPT mRNA, SP levels, and airway hyperreactivity.
Conclusions:
- Local application of ds PPT RNA via RNAi is an effective method to prevent the activation of the noncholinergic system in the airways.
- This study demonstrates a targeted molecular strategy to counteract LPS-induced airway hyperreactivity, highlighting the role of tachykinins.